+Compare
XWEL
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
8.61M

XWEL XWELL Forecast, Technical & Fundamental Analysis

a spa service

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for XWEL with price predictions
07:00 PM EST Nov 26, 2023

XWEL in upward trend: price rose above 50-day moving average on November 27, 2023

XWEL moved above its 50-day moving average on November 27, 2023 date and that indicates a change from a downward trend to an upward trend. In of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XWEL's RSI Indicator exited the oversold zone, of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 09, 2023. You may want to consider a long position or call options on XWEL as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where XWEL advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XWEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XWEL broke above its upper Bollinger Band on November 16, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XWEL entered a downward trend on November 13, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. XWEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.431) is normal, around the industry mean (25.079). P/E Ratio (0.000) is within average values for comparable stocks, (79.545). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.242). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.275) is also within normal values, averaging (45.510).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XWEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 702%. ICCM experienced the highest price growth at 85%, while SLDX experienced the biggest fall at -83%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

XWEL is expected to report earnings to fall 42.86% to -80 cents per share on November 15

XWELL XWEL Stock Earnings Reports
Q3'23
Est.
$-0.80
Q2'23
Missed
by $1.33
Q1'23
Beat
by $0.06
Q4'22
Missed
by $0.11
Q3'22
Missed
by $0.01
The last earnings report on August 14 showed earnings per share of -139 cents, missing the estimate of -7 cents. With 8.50K shares outstanding, the current market capitalization sits at 8.61M.
A.I. Advisor
published General Information

General Information

a spa service

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Other Consumer Services
Address
254 West 31st Street
Phone
+1 212 750-9595
Employees
483
Web
https://www.xwell.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RIOT12.861.04
+8.80%
Riot Platforms
MAS59.49-0.29
-0.49%
Masco Corp
GSBC50.98-0.32
-0.62%
Great Southern Bancorp
BNTC3.05-0.13
-4.09%
Benitec Biopharma
BRAG5.30-0.28
-5.02%
Bragg Gaming Group

XWEL and

Correlation & Price change

A.I.dvisor tells us that XWEL and DRIO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XWEL and DRIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XWEL
1D Price
Change %
XWEL100%
+8.74%
DRIO - XWEL
31%
Poorly correlated
N/A
COCH - XWEL
25%
Poorly correlated
+13.01%
ALGN - XWEL
22%
Poorly correlated
-1.24%
TWST - XWEL
22%
Poorly correlated
-1.69%
CHEK - XWEL
21%
Poorly correlated
-7.76%
More

Groups containing XWEL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XWEL
1D Price
Change %
XWEL100%
+8.74%
Medical Specialties
(undefined stocks)
14%
Poorly correlated
+0.15%
Medical Specialties
(undefined stocks)
14%
Poorly correlated
+0.15%
personal
(undefined stocks)
10%
Poorly correlated
-0.06%
consumer services
(undefined stocks)
10%
Poorly correlated
-0.33%